Norwest Venture sells 9.3% stake in Thyrocare Technologies

29 Aug 2017 Evaluate

Venture Capital firm Norwest Venture Partners has offloaded 9.3 per cent stake in diagnostics chain Thyrocare Technologies for an estimated over Rs 335 crore through open market transactions. The shares were picked by Reliance Mutual Fund and Birla Sunlife Mutual Fund, among others.

Norwest Venture Partners VII-A-Mauritius has sold a total of 50 lakh shares of the company in a price range of Rs 670- 670.88 apiece.

Thyrocare Technologies is one of the leading pan-India diagnostic chains and conducts an array of medical diagnostic tests and profiles of tests that center on early detection and management of disorders and diseases.

Thyrocare Tech. Share Price

922.20 -26.85 (-2.83%)
31-Oct-2024 16:01 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7000.00
Max Healthcare Inst 1008.35
Narayana Hrudayalay 1265.30
Aster DM Healthcare 442.70
Global Health 1105.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.